Louisiana's Claim of Abortion Pill Drink Spiking Lacks Evidence, Supreme Court Case Reveals

Louisiana's Controversial Lawsuit Against the FDA

Louisiana has filed a lawsuit against the U.S. Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), and several officials—including Robert F. Kennedy Jr.—over the FDA's 2023 decision to eliminate the in-person dispensing requirement for mifepristone, an abortion pill. The state argues that this change enables reproductive coercion, claiming that men are secretly spiking women's drinks with abortion pills obtained through remote prescriptions.

No Evidence Supports Louisiana's Claim

Despite Louisiana's assertions, there is no verifiable evidence that such incidents are occurring at any significant scale. The state's complaint does not cite a single documented case of drink spiking with abortion pills. Experts note that if this were happening frequently, it would likely be widely reported in local and national news, with prosecutions and lawsuits following.

An analysis of available reports reveals only seven potential cases since 2023, including:

• Four cases from Texas
• One case from Massachusetts
• One case from Illinois
• One case from Ohio

Many of these allegations remain unproven, and it is unclear whether remote prescribing played any role in the incidents. A Heritage Foundation report from March 2024 identified only three recent cases of abortion-pill drink spiking, with four additional cases dating back to 2007.

The Case of Rosalie Markezich

The lawsuit centers on Rosalie Markezich, a Louisiana resident who alleges she was coerced into taking abortion pills against her will. According to her complaint, Markezich was pregnant in 2023 and did not want an abortion but felt pressured due to her partner's demands. Her case highlights concerns about reproductive coercion in states with strict abortion bans.

Criticism of Louisiana's Argument

Critics argue that Louisiana's claim—that in-person prescribing requirements could prevent abortion-pill coercion—lacks logical foundation. Even with stricter prescribing rules, women in controlling or abusive relationships may still face reproductive coercion. The FDA's decision to allow remote prescribing was intended to improve access to abortion in states where bans have made the procedure largely unavailable.

"Women like Rosalie Markezich may certainly feel pressured by partners to take abortion pills. But fear of abuse doesn't stop at a doctor's door, and women with controlling or violent partners could still face reproductive coercion no matter how many prescribing rules are put in place."

Implications for Abortion Access and Policy

The Supreme Court is now reviewing Louisiana's case, which could have significant implications for abortion access and regulation. The FDA's decision to remove the in-person dispensing requirement has been a critical factor in enabling mail-order prescriptions, particularly in states with abortion bans. Louisiana's lawsuit challenges this policy, arguing that it enables abuse and coercion.

However, opponents of the lawsuit contend that the state's claims are speculative and that the evidence does not support the notion that remote prescribing facilitates drink spiking or reproductive coercion. The case raises important questions about balancing abortion access with concerns about potential misuse of medication.